Published online before print August 7, 2008

This Article Full Text Full Text (PDF) Supplemental Material All Versions of this Article: jmoldx.2008.080056v1 10/5/424    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Audrezet, M.-P. Articles by Ferec, C. PubMed PubMed Citation Articles by Audrezet, M.-P. Articles by Ferec, C.

Journal of Molecular Diagnostics 2008, Vol. 10, No. 5
Copyright © 2008 American Society for Investigative Pathology & Association for Molecular Pathology
DOI: 10.2353/jmoldx.2008.080056

Technical Advances

Validation of High-Resolution DNA Melting Analysis for Mutation Scanning of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene

Marie-Pierre Audrezet^*, Aurélia Dabricot, Cédric Le Marechal^* and Claude Ferec^*

From INSERM, U613, * Brest F-29200, France; the Faculté de Médecine et des Sciences de la Santé, UMR-S613, University of Brest, Brest; Etablissement Français du Sang–Bretagne, Brest; Laboratoire de Génétique Moléculaire, Centre Hospitalier Universitaire de Brest, Hop Morvan, Brest, France

Abstract

High-resolution melting analysis of polymerase chain reaction products for mutation scanning, which began in the early 2000s, is based on monitoring of the fluorescence released during the melting of double-stranded DNA labeled with specifically developed saturation dye, such as LC-Green. We report here the validation of this method to scan 98% of the coding sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. We designed 32 pairs of primers to amplify and analyze the 27 exons of the gene. Thanks to the addition of a small GC-clamp at the 5' ends of the primers, one single melting domain and one identical annealing temperature were obtained to co-amplify all of the fragments. A total of 307 DNA samples, extracted by the salt precipitation method, carrying 221 mutations and 21 polymorphisms, plus 20 control samples free from variations (confirmed by denaturing high-performance liquid chromatography analysis), was used. With the conditions described in this study, 100% of samples that carry heterozygous mutations and 60% of those with homozygous mutations were identified. The study of a cohort of 136 idiopathic chronic pancreatitis patients enabled us to prospectively evaluate this technique. Thus, high-resolution melting analysis is a robust and sensitive single-tube technique for screening mutations in a gene and promises to become the gold standard over denaturing high-performance liquid chromatography, particularly for highly mutated genes such as CFTR, and appears suitable for use in reference diagnostic laboratories.